Adage Capital Partners
CATX icon

Adage Capital Partners’s Perspective Therapeutics CATX Stock Holding History

Adage Capital Partners’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-750,000
Closed -$10M – 889
2024
Q3 		$10M Buy
750,000
+368,360
+97% +$4.9M 0.02% 602
2024
Q2 		$3.8M Buy
+381,640
New +$5.52M 0.01% 736

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Adage Capital Partners's CATX Position: Q4 2024 in Review

Adage Capital Partners sold out of Perspective Therapeutics (CATX) in Q4 2024, closing a stake of 750,000 shares — an estimated $10M sold.

Adage Capital Partners first reported a position in CATX in Q2 2024 and held it in 2 quarters. The position peaked at $10M in Q3 2024. 135 funds tracked by Wall St. Rank hold CATX as of Q4 2024.

  • Adage Capital Partners reported no remaining Perspective Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 750,000 Perspective Therapeutics shares in Q4 2024, an estimated $10M.
  • Adage Capital Partners first reported a position in Perspective Therapeutics in Q2 2024 and held it in 2 quarters.
  • Adage Capital Partners's Perspective Therapeutics position peaked at $10M in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.